Fabien Calvo is Chief Scientific Officer for Cancer Core Europe, a consortium of six Comprehensive Cancer Centres including Cambridge Cancer Centre, the German Cancer Research Centre (DKFZ) and the National Centre for Tumour Diseases (NCT) in Heidelberg, the Val d’Hebron Institute of Oncology in Barcelona, The Karolinska Insttitute in Stockholm, Gustave Roussy Cancer Campus Grand Paris, and the National Cancer Institute (NKI) in Amsterdam.
His role as CSO is to organize and coordinate medical research and scientific activities and assist the consortium in developing a global vision and planning and delivering the implementation of the strategy. Fabien Calvo is currently Professor of Pharmacology at University of Paris-Denis Diderot. From April 2007 to September 2014, Fabien Calvo was Deputy Director General of the National Cancer Institute of France, in charge of Research and Innovation Programs. He launched with the USA, Canada, UK and Germany, the International Cancer Genome Consortium for which he chairs the Scientific Planning Committee of ICGCmed.